Continuous hyperfractionated accelerated therapy in non-small-cell lung cancer
- PMID: 9310628
- DOI: 10.1016/S0140-6736(05)62072-7
Continuous hyperfractionated accelerated therapy in non-small-cell lung cancer
Comment on
-
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee.Lancet. 1997 Jul 19;350(9072):161-5. doi: 10.1016/s0140-6736(97)06305-8. Lancet. 1997. PMID: 9250182 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
